Checkpoint Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $41 | $0 | $6 | $31 |
Gross Profit | 41 | -8,497 | -8,292 | -5,465 |
EBITDA | -6,673 | -10,948 | -10,169 | -7,701 |
EBIT | -10,991 | -10,212 | -15,402 | |
Net Income | -6,670 | -10,945 | -19,128 | -5,724 |
Net Change In Cash | 41 | 0 | 6 | 31 |
Free Cash Flow | -6,240 | -6,474 | -6,833 | -14,750 |
Cash | 4,951 | 11,241 | 4,928 | 1,772 |
Basic Shares | 36,526 | 32,930 | 27,285 | 19,988 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $103 | $192 | $268 | $1,069 |
Gross Profit | -43,463 | -49,633 | 268 | 1,069 |
EBITDA | -52,148 | -53,882 | -56,670 | -23,201 |
EBIT | -52,315 | -58,333 | -56,723 | -23,201 |
Net Income | -51,847 | -66,915 | -56,617 | -22,961 |
Net Change In Cash | 103 | 192 | 268 | 1,069 |
Cost of Revenue | 13,963 | 14,695 | ||
Free Cash Flow | -47,590 | -57,554 | -26,306 | -16,551 |
Cash | 4,928 | 12,068 | 54,735 | 40,772 |
Basic Shares | 18,742 | 8,835 | 7,603 | 5,583 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.18 |
2024-03-31 | -$0.33 |
2023-12-31 | -$1.10 |
2023-09-30 | -$0.29 |
